Opportunities
Search

Expected Impact:Applicants are expected to define, calculate, explain and achieve the expected impacts as described in the Award criterion ‘Impact’ (see Call document section 2 and 9).Objective:The aim is to facilitate the transition toward a sustainable, circular, energy-efficient and climate-resilient economy, a toxic-free environment and at protecting, restoring and improving the quality of the environment in line with the European Green Deal and recent policy developments.The specific objective is to cover one or more of the topics as fully defined in section 2 of the Call document (under the heading LIFE-2026-SAP-ENV-GOV).Please note that the assessment of the extent to which the project is in line with the specific priorities of the call (part of Award criterion 1) will be done exclusively on the basis of the topics identified and described under section ‘Compliance with LIFE progr...

Expected Outcome:Successful proposals will contribute to the updated EU Bioeconomy Strategy, the Circular Economy Act, the Clean Industrial Deal, the European Chemical Industry Action Plan and the Chemicals Strategy for Sustainability.Projects results are expected to contribute to the following expected outcomes:Enhancing competitiveness, efficiency, sustainability, circularity and safety of industrial biorefineries.Efficient, selective and scalable separation and purification technology platform(s) with high potential to be integrated within existing and/or new biorefineries.Purity and stability of targeted intermediates/product(s) compatible with further conversion requirements. Scope:While significant advancements have been made in recent years in the development of core biorefinery processes, challenges remain in separation and purification steps.Separation and purification, both ups...

Expected Outcome:Successful proposals will contribute to updated EU Bioeconomy Strategy, the Clean Industrial Deal, the European Chemical Industry Action Plan and the upcoming Circular Economy Act.Projects results are expected to contribute to the following expected outcomes:Identification of technical, market and regulatory barriers and possible solutions for industry to ‘switch to bio-based’.Contribution to filling the gap between bio-based sectors and the broader industrial landscape. Scope:While the share of bio-based products and processes in traditionally non-bio-based markets has been growing substantially in recent years, many non-bio-based, partially bio-based and more traditional bio-based industries (such as food industry) still perceive market and regulatory situations as uncertain and may therefore be reluctant to invest in new bio-based value chains. These uncertainties may...

Expected Outcome:Successful proposals will contribute to the EU Forest Strategy for 2030, the EU Biodiversity Strategy 2030, the Carbon Removal Certification Framework Regulation, the updated EU Bioeconomy Strategy and the upcoming Circular Economy Act.Projects’ results are expected to contribute to the following expected outcomes:Increased availability of bio-based chemicals and/or bio-based materials from woody residues.Increased sustainability of forest-based value chains in cooperation with local forestry owners/cooperatives.Improved end-of-life (EoL) of bio-based products from woody residues. Scope:Besides thin branches, leaves and needles, which are usually left on the soil to maintain the long-term viability of the forest and soil in good condition, forestry and forest industry operations generate large amounts of woody residues which are typically used for energy or low value app...

Expected Outcome:Successful proposals will contribute to the updated EU Bioeconomy Strategy, the Chemicals Strategy for Sustainability, the EU Strategy for Sustainable and Circular Textiles, the Clean Industrial Deal, and the Ecodesign Sustainable Products Regulation. Indirect contribution is expected towards the objectives of the Horizon Europe Mission "Restore our Ocean and Waters by 2030" in particular to Obj 2: "Prevent and eliminate pollution of our oceans, seas and waters”.Projects results are expected to contribute to the following expected outcomes:Wider availability of natural and/or man-made bio-based fibres meeting market requirements.Scalable production processes for novel man-made and/or modified natural fibres.Enhanced circularity and prevent microplastics release compared to benchmarks. Scope:Fossil-based synthetic textile fibre production has grown significantly, reaching...

Expected Outcome:Successful proposals will contribute to the updated EU Bioeconomy Strategy, Farm to Fork Strategy, the Horizon Europe Mission ‘A Soil Deal for Europe’, in particular the objectives: ‘Reduce soil pollution and enhance restoration’, the European Chemical Industry Action Plan as well as the Clean Industrial Deal.Projects results are expected to contribute to the following expected outcomes:Full industrial scale biorefinery and related value chain(s) for the sustainable production of bio-based fertilisers and/or crop protection solutions.Increased availability of cost-competitive and SSbD bio-based alternatives for fertilising and/or crop protection products with suitable agronomic efficacy.Reduced reliance on synthetic/mineral agricultural chemical products.Increased EU strategic autonomy, resilience and competitiveness through a robust cooperation among bio-based industrie...

Expected Outcome:Successful proposals will contribute to the implementation of the Zero Pollution Action Plan, the Circular Economy Action Plan, the Ecodesign for Sustainable Products Regulation, the Chemicals Strategy for Sustainability and the Chemical Industry Action Plan. They will provide solutions in line with the objectives of the EU legislation on waste but also the Horizon Europe Mission "Restore our Ocean and Waters by 2030" in particular to Objective 2: "Prevent and eliminate pollution of our oceans, Seas and waters” as well as the Horizon Europe Mission “A Soil Deal for Europe”, in particular objectives “Reduce soil pollution and enhance restoration”.Projects results are expected to contribute to the following expected outcomes:Wider availability of bio-based additives targeting high functional properties, stability and compatibility with polymers/matrices.Contribution to imp...

Expected Outcome:Successful proposals will contribute to the Circular Economy Action Plan, the Chemicals Strategy for Sustainability and the Ecodesign for Sustainable Products Regulation.Projects results are expected to contribute to the following expected outcomes:Wider availability of bio-based films and coatings for packaging products.Improved technical performances of packaging products compared to fossil based and/or bio-based benchmarks.Improved circularity of packaging products against specified market benchmarks taking into account production, use and EoL. Scope:Many research projects have focused on developing and piloting bio-based coatings and films for application in food and non-food packaging. When targeting packaging, a primary challenge is achieving adequate barrier properties (against oxygen, moisture, grease and volatiles), as bio-based materials are typically more hydr...

The Combinatorics program supports research on discrete structures and includes algebraic, enumerative, existential, extremal, geometric, and probabilistic combinatorics, including graph theory. Conferences Principal Investigators should carefully read the program solicitation "Conferences and Workshops in the Mathematical Sciences" (link below) to obtain important information regarding the substance of proposals for conferences, workshops, summer/winter schools, and similar activities. Conference proposals must be submitted at least six months in advance of the conference, and in the same fiscal year (which begins October 1) if possible.

The program in Foundations supports research in mathematical logic and the foundations of mathematics, including proof theory, recursion theory, model theory, set theory, and infinitary combinatorics. Conferences Principal Investigators should carefully read the program solicitation "Conferences and Workshops in the Mathematical Sciences" (link below) to obtain important information regarding the substance of proposals for conferences, workshops, summer/winter schools, and similar activities. Conference and workshop proposals should be submitted eight months before the requested start date.

Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Platform Clinical Translation Award supports the translational development and/or early-phase clinical trials for broadly applicable clinical technologies that will address urgent and complex needs related to two congressionally directed FY26 PRMRP topic areas. The platform product in development should address one of the FY26 PRMRP portfolio-specific strategic goals and address the health care needs of military Service Members, Veterans and their Families.Distinctive Features:Allows for multiple Principal Investigators (PIs). The proposed experiments may represent a single project led by a single PI, or it may consist of partnerships between principal investigators that will occur synergistically to advance a platform product. One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. Up to two additional PIs can be identified as Partnering PIs. If recommended for funding, each PI will be named on separate awards to the recipient organization(s).Requires a PI-convened external advisory board with patient advocate participation. The patient advocate must be a person living with, or a family member or caretaker of someone with, a disease or condition addressed in one of the applicant-selected congressionally directed FY26 PRMRP topic areas.Funding Details: The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $30M to fund approximately two Platform Clinical Transl...

Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have significant impact on the treatment and management of a disease or condition addressed in one of the congressionally directed FY26 PRMRP topic areas and FY26 PRMRP strategic goals.Distinctive Features: Must support a clinical trial. Supports two different application categories, based on the phase of planning for the clinical trial: Clinical Trial Only or Clinical Trial with Planning Phase. The Clinical Trial with Planning Phase option is intended to support the final phase of regulatory activities and planning activities that are necessary to be completed prior to initiation of the clinical trial. The planning phase cannot be used to finalize the intervention or support animal studies. Applications that already have regulatory approvals in place and are submitting to the Clinical Trial Only option may be prioritized over those requesting the Planning Phase option. Animal studies are not supported. Studies must complete all preclinical empirical laboratory work prior to the award start date.Supports three funding levels, each offered with and without a Planning Phase:Funding Level 1: Supports phase 0 or phase 1 clinical trials or non-phased trials with fewer than 100 participants.Funding Level 2: Supports phase 2 clinical trials or non-phased trials with fewer than 300 participants.Funding Level 3: Supports phase 3 clinical trials or non-phased trials with more than 300 participants.Funding D...

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Synergistic Idea Award (SIA) supports new ideas that represent synergistic approaches to neurofibromatosis (NF) research involving two or three Principal Investigators (PIs). These investigators should utilize their complementary and synergistic perspectives to address a central problem or question in NF research. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project.Distinctive Features:• Partnering Principal Investigators: One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. An additional one or two PI(s) will be identified as a Partnering PI. Each partner will be recognized as a PI, submit a separate application (even if the partners are at the same organization), and receive an individual award.

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in neurofibromatosis (NF) research. Studies supported by this award mechanism should lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design.Distinctive Features:• Innovation: The proposed research project should be innovative. Innovative research may introduce a novel paradigm, challenge existing paradigms, examine existing problems from novel perspectives, or exhibit other highly creative qualities.• Preliminary Data: Preliminary and/or published data is encouraged but not required.

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Neurofibromatosis Research Academy – Scholar Award (NFRA-SA) supports early-career independent investigators (Scholars) joining the Neurofibromatosis Research Academy to pursue a neurofibromatosis project that may include basic, translational, and/or clinical research. The proposed research should address at least one of the FY26 NFRP Areas of Emphasis, under the leadership of the NFRA Director and Deputy Director. The overarching goal of the NFRA is to conduct innovative and impactful research in the field of neurofibromatosis disorders while developing successful, highly productive NF researchers in a collaborative research and career development environment.Distinctive Features:• Scholar: The Scholar, named as the Principal Investigator, must be less than 10 years of completion of their terminal degree by the time of the application deadline (excluding time spent in residency, clinical training, or on family medical leave).• Career Guide: This award mechanism requires each Scholar to designate a Career Guide for guidance. The Career Guide is not required to be at the same institution as the Scholar; however, if the (primary) Career Guide is from a different institution, the application must identify a secondary Career Guide at the Scholar’s institution.

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Investigator-Initiated Research Award (IIRA) supports high-impact research that addresses a critical need and has the potential to make important contributions to the field of neurofibromatosis disorders or advance patient care. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project.Distinctive Features: This award mechanism offers two funding levels based on participation in two optional features:• Open Science Initiative: Catalyzes research for neurofibromatosis through early access to data and data sharing within the neurofibromatosis community.• Optional Qualified Collaborator: Encourages collaborative research between basic scientists and clinical researchers, and between academic and biotechnology scientists.The funding levels are defined as follows:• Level 1: Applications without an optional feature.• Level 2: Applications including one of the optional features.

Buyer: AZIENDA USL DI BOLOGNA | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-22

Buyer: Vegagerðin | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-09-22

Buyer: Kamer van Koophandel | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-22

Buyer: ZVS Kreis Bernkastel-Wittlich | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-22

Buyer: Regio Gooi en Vechtstreek | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-22

Buyer: Inkoopsamenwerking Noord Veluwe (ISNV) | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-22

Buyer: Vendée Habitat | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-22

Buyer: Bizob | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-22

Buyer: Consorzio di Sviluppo Economico della Venezia Giulia | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-09-22